A Phase 2b Study to Assess the Effect of Dose Interval on the Effectiveness of a Protein-based Covid-19 Vaccine (Spikogen® Vaccine)
Latest Information Update: 15 Apr 2024
At a glance
- Drugs COVAX 19 (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Vaxine
- 07 Apr 2024 Planned End Date changed from 25 Feb 2024 to 30 Jun 2024.
- 28 Mar 2023 Planned End Date changed from 1 Mar 2023 to 25 Feb 2024.
- 12 May 2022 Status changed from recruiting to active, no longer recruiting.